← Back to Clinical Trials
Recruiting NCT07185789

NCT07185789 Multidimensional Intervention in Mexican Schoolchildren

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07185789
Status Recruiting
Phase —
Sponsor Mexican National Institute of Public Health
Condition Childhood Obesity
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2023-11-07
Primary Completion 2025-07-28

Eligibility & Interventions

Sex All sexes
Min Age 9 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Healthy and Sustainable EatingMovement behaviorsPsychosocial determinants

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2023-11-07 with a primary completion date of 2025-07-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aims is to evaluate the effects of an multidimensional intervention on the physical-built and social environment around schools and the nutritional status of the school population, through a randomized community trial, in schools in 3 states of the Mexican Republic, using anthropometric indicators, biological, psychological, behavioral and environmental. The main questions it aims to answer are: 1. What are the main risk and protective factors for overweight and obesity in the school environment and in the environments around schools in primary education schools in three states of the Mexican Republic? 2. Is there a relationship between risky eating behaviors and the body mass index of schoolchildren? 3. Are the strategies that are being implemented effective in reducing the presence of risk factors and increasing the presence of protective factors for overweight and obesity in the school environment and in the environments around schools? 4. Are the strategies that are being implemented effective in reducing the presence of risk factors and increasing the protective factors for overweight and obesity in the family environment?

Eligibility Criteria

Inclusion Criteria: * Fourth grade elementary schools children from schools that belong to Federal entities: Campeche, Morelos and Mexico City, with morning schedule, from 8:00 to 12:30 or extended schedule, from 8:00 to 14:00hrs. * For Morelos State, elementary schools will be sought to be private, with at least 1000 enrollement students, with morning schedule, from 8:00 to 12:30 or extended schedule, from 8:00 to 14:00hrs. Exclusion Criteria: * Children that don´t correspond to the selected shifts.

Contact & Investigator

Central Contact

EDGAR DENOVA GUTIERREZ, PhD

✉ edenovag@gmail.com

📞 5554322986

Principal Investigator

Simon Barquera Cervera, PhD

STUDY DIRECTOR

National Institute of public Health

Frequently Asked Questions

Who can join the NCT07185789 clinical trial?

This trial is open to participants of all sexes, aged 9 Years or older, up to 12 Years, studying Childhood Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07185789 currently recruiting?

Yes, NCT07185789 is actively recruiting participants. Contact the research team at edenovag@gmail.com for enrollment information.

Where is the NCT07185789 trial being conducted?

This trial is being conducted at Cuernavaca, Mexico.

Who is sponsoring the NCT07185789 clinical trial?

NCT07185789 is sponsored by Mexican National Institute of Public Health. The principal investigator is Simon Barquera Cervera, PhD at National Institute of public Health. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology